Milestones

Click on each one of the boxes below to learn more about MMV's work in the area mentioned. 

SDG 1: Access to antimalarials is key to eliminating malaria, a major cause of poverty

SDG 3: MMV's work supports target 3.3, which aims to end the epidemics of AIDS, tuberculosis, malaria and NTDs

SDG 5: MMV prioritizes the needs of women and girls, a key population at risk of malaria

SDG 8: Availability of antimalarials for workers and their families decreases absenteeism in the workplace

SDG 9: MMV invests in partnerships, including those which strengthen capacity in Africa

SDG 10: MMV's vision is a world in which antimalarials cure and protect the most vulnerable

SDG 17: Partnership is at the core of MMV's business model

Almost 3 million lives estimated to have been saved by MMV-supported medicines

Graphic: MMV's key milestones in 2020

>25 drug targets validated since 1999

MMV's key achievements from 1999-2019

150 active partners in MMV's network, working to help defeat malaria

Graphic: MMVs key achievements from 1999-2014

USD 1 = USD 3.5 of investment impact thanks to direct and in-kind support from partners